Literature DB >> 8835405

Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.

L Frøyland1, H Vaagenes, D K Asiedu, A Garras, O Lie, R K Berge.   

Abstract

Fish oils rich in n-3 fatty acids have been shown to decrease plasma lipid levels, but the underlying mechanism has not yet been elucidated. This investigation was performed in order to further clarify the effects of purified ethyl esters of eicosapentaenoic acid (EPA-EE) and docosahexaenoic acid (DHA-EE) on lipid metabolism in rats. The animals were fed EPA-EE, DHA-EE, palmitic acid, or corn oil (1 g/kg/d) by orogastric intubation along with a chow background diet for three months. At the end the animals were sacrificed. Plasma and liver lipids were measured, as well as lipid-related enzyme activities and mRNA levels. The fatty acid composition of plasma and different tissues was also determined. This study shows that, compared to the corn oil control, EPA-EE and DHA-EE lowered plasma cholesterol level, whereas only EPA-EE lowered the amount of plasma triacylglycerol. In liver peroxisomes, both EE preparations increased fatty acyl-CoA oxidase FAO activities, and neither altered 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase activities. In liver microsomes, EPA-EE raised HMG-CoA reductase and acyl-CoAicholesterol acyltransferase activities, whereas DHA-EE lowered the former and did not affect the latter. Neither product altered mRNA levels for HMG-CoA reductase, low density lipoprotein-receptor, or low density lipoprotein-receptor related protein. EPA-EE lowered plasma triacylglycerol, reflecting lowered very low density lipoprotein secretion, thus the cholesterol lowering effect in EPA-EE-treated rats may be secondary to the hypotriacylglycerolemic effect. An inhibition of HMG-CoA reductase activity in DHA-EE treated rats may contribute to the hypocholesterolemic effect. The present study reports that 20:5n-3, and not 22:6n-3, is the fatty acid primarily responsible for the triacylglycerol lowering effect of fish oil. Finally, 20:5n-3 was not converted to 22:6n-3, whereas retroconversion of 22:6n-3 to 20:5n-3 was observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835405     DOI: 10.1007/bf02522617

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  66 in total

1.  Effects of certain pure long chain polyunsaturated fatty acid esters on the blood lipids of man; preliminary studies on the use of polyunsaturated fatty acid in atherosclerosis.

Authors:  H E WORNE; L W SMITH
Journal:  Am J Med Sci       Date:  1959-06       Impact factor: 2.378

2.  Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells.

Authors:  M Grønn; E Christensen; T A Hagve; B O Christophersen
Journal:  Biochim Biophys Acta       Date:  1992-04-08

Review 3.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

4.  Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil.

Authors:  D R Sullivan; T A Sanders; I M Trayner; G R Thompson
Journal:  Atherosclerosis       Date:  1986-08       Impact factor: 5.162

5.  Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes.

Authors:  J O Nossen; A C Rustan; S H Gloppestad; S Målbakken; C A Drevon
Journal:  Biochim Biophys Acta       Date:  1986-10-24

6.  Increased cholesterol synthesis in Chinese hamster ovary cells deficient in peroxisomes.

Authors:  G P van Heusden; J R van Beckhoven; R Thieringer; C R Raetz; K W Wirtz
Journal:  Biochim Biophys Acta       Date:  1992-06-05

7.  The Zellweger syndrome: deficient conversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) and normal delta 4-desaturase activity in cultured skin fibroblasts.

Authors:  M Grønn; E Christensen; T A Hagve; B O Christophersen
Journal:  Biochim Biophys Acta       Date:  1990-05-22

8.  Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells.

Authors:  S H Wong; E A Fisher; J B Marsh
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

9.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase is present in peroxisomes in normal rat liver cells.

Authors:  G A Keller; M C Barton; D J Shapiro; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Authors:  A Voss; M Reinhart; S Sankarappa; H Sprecher
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

View more
  12 in total

1.  Hypolipidemic Effects of Phospholipids (PL) Containing n-3 Polyunsaturated Fatty Acids (PUFA) Are Not Dependent on Esterification of n-3 PUFA to PL.

Authors:  Kenji Fukunaga; Ryota Hosomi; Midori Fukao; Kazumasa Miyauchi; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida
Journal:  Lipids       Date:  2016-01-13       Impact factor: 1.880

2.  Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference.

Authors:  L Madsen; A C Rustan; H Vaagenes; K Berge; E Dyrøy; R K Berge
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

3.  Effect of 18:1n-9, 20:5n-3, and 22:6n-3 on lipid accumulation and secretion by Atlantic salmon hepatocytes.

Authors:  A Vegusdal; T Gjøen; R K Berge; M S Thomassen; B Ruyter
Journal:  Lipids       Date:  2005-05       Impact factor: 1.880

4.  3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver.

Authors:  L Madsen; R K Berge
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

5.  Minor lipid metabolic perturbations in the liver of Atlantic salmon (Salmo salar L.) caused by suboptimal dietary content of nutrients from fish oil.

Authors:  Monica Sanden; Nina S Liland; Øystein Sæle; Grethe Rosenlund; Shishi Du; Bente E Torstensen; Ingunn Stubhaug; Bente Ruyter; Nini H Sissener
Journal:  Fish Physiol Biochem       Date:  2016-05-06       Impact factor: 2.794

6.  Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues.

Authors:  G Calviello; P Palozza; P Franceschelli; G M Bartoli
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

7.  Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats.

Authors:  Bruce J Holub; Patricia Swidinsky; Eek Park
Journal:  Lipids       Date:  2011-03-06       Impact factor: 1.880

8.  Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Jaividhya Dasarathy; Amer Khiyami; Lisa Yerian; Carol Hawkins; Ruth Sargent; Arthur J McCullough
Journal:  J Clin Gastroenterol       Date:  2015-02       Impact factor: 3.062

9.  Effect of combination of dietary fish protein and fish oil on lipid metabolism in rats.

Authors:  Ryota Hosomi; Kenji Fukunaga; Hirofumi Arai; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida
Journal:  J Food Sci Technol       Date:  2011-03-30       Impact factor: 2.701

10.  Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice.

Authors:  Xiaofang Liu; Yong Xue; Chunhua Liu; Qiaoming Lou; Jingfeng Wang; Teruyoshi Yanagita; Changhu Xue; Yuming Wang
Journal:  Lipids Health Dis       Date:  2013-07-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.